111 filings
8-K
HRMY
Harmony Biosciences Holdings Inc
29 May 24
Submission of Matters to a Vote of Security Holders
5:01pm
8-K
HRMY
Harmony Biosciences Holdings Inc
3 May 24
Departure of Directors or Certain Officers
8:00am
10-Q
2024 Q1
HRMY
Harmony Biosciences Holdings Inc
Quarterly report
30 Apr 24
8:00am
8-K
HRMY
Harmony Biosciences Holdings Inc
30 Apr 24
WAKIX® (pitolisant) Net Revenue of $154.6 Million for First Quarter 2024; ~30% Growth Year-over-Year
7:45am
ARS
2023 FY
HRMY
Harmony Biosciences Holdings Inc
11 Apr 24
Annual report to shareholders
9:44am
8-K
gk3w nul6iah
11 Apr 24
Entry into a Material Definitive Agreement
8:30am
DEFA14A
qrhwenbko
11 Apr 24
Additional proxy soliciting materials
8:18am
S-8
qnyxae92cuy5 pqmh7ny
22 Feb 24
Registration of securities for employees
4:14pm
8-K
1aoxpd3 w6et
22 Feb 24
Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
7:45am
8-K
3xp5bp 73
8 Jan 24
Results of Operations and Financial Condition
8:30am
8-K/A
mxd18l7 zrww
7 Dec 23
Consolidated Financial Statements
4:06pm
8-K
kmsfdwvjm7uoqm w0
8 Nov 23
Harmony Biosciences Appoints
8:30am
8-K
djewxrnswia4siof hsk
31 Oct 23
Harmony Biosciences Reports Strong Third Quarter 2023 Financial Results
7:45am
8-K
h24ng536e
13 Oct 23
Harmony Biosciences Announces Topline Data from Phase 3 Intune Study Evaluating Pitolisant In Patients with Idiopathic Hypersomnia
8:15am
SC TO-T/A
slmhf3vbxd8vcg c0hw
11 Oct 23
Third party tender offer statement (amended)
8:31am
8-K
d0zhszjp
11 Oct 23
Harmony Biosciences Completes Acquisition of Zynerba
8:15am